Without enough functional von Willebrand factor, affected dogs may bleed excessively even from minor wounds or routine surgical procedures.
vWD1 is considered the most common and generally the mildest form of von Willebrand Disease found in dogs, although the severity of symptoms can vary significantly between individuals. Some dogs may live for years without obvious signs, while others may experience noticeable bleeding problems throughout their lives. Because symptoms can sometimes remain hidden until surgery, injury, or trauma occurs, genetic testing is an important tool for early identification.
Dogs affected by vWD1 may show symptoms such as prolonged bleeding from cuts, frequent nosebleeds, bleeding gums, blood in the urine or stool, excessive bruising, or extended bleeding after surgery, nail trimming, or tooth loss. Female dogs may also experience prolonged bleeding during heat cycles or after giving birth. In severe cases, uncontrolled bleeding can become life-threatening if not treated promptly.
von Willebrand Disease Type 1 is inherited in a genetic pattern that varies slightly between breeds but is commonly considered autosomal recessive with incomplete dominance. This means dogs can be genetically clear, carriers, or affected depending on the number of mutated gene copies inherited from their parents. Carrier dogs may have reduced levels of von Willebrand factor without showing significant symptoms, while affected dogs generally have a higher risk of bleeding complications.
The vWD1 genetic test identifies whether a dog carries the mutation associated with the disease. Testing is usually performed using a simple cheek swab or blood sample. Laboratory analysis examines the dog’s DNA to determine if the mutation is absent, present in one copy, or present in two copies. Genetic testing allows breeders and owners to understand the dog’s risk level and make informed decisions regarding breeding and healthcare management.
Genetic screening is especially valuable for breeding programs because affected or carrier dogs can pass the mutation to future generations. By testing breeding dogs before mating, breeders can reduce the likelihood of producing puppies at risk for bleeding disorders while maintaining the overall health and genetic diversity of the breed. Responsible breeding practices play an important role in limiting the spread of vWD1 within susceptible breeds.
Although there is currently no cure for von Willebrand Disease Type 1, most affected dogs can live normal and active lives with appropriate management. Preventive care focuses on minimizing injury risks and preparing for situations where bleeding may occur. Veterinarians may recommend additional precautions before surgery or dental procedures, including blood clotting evaluations or plasma transfusions if necessary. Certain medications that interfere with clotting may also need to be avoided.
Early diagnosis through genetic testing helps owners and veterinarians develop safe healthcare plans for affected dogs. Knowing a dog’s genetic status allows for careful monitoring and proper preparation before any medical procedures, reducing the risk of serious bleeding complications.
Testing for von Willebrand Disease Type 1 demonstrates a commitment to responsible dog ownership and ethical breeding practices. Identifying carriers and affected dogs helps improve breed health, supports informed breeding decisions, and contributes to the long-term welfare and wellbeing of future generations of dogs.
